
CAMKK2 inhibitor 4t
CAS No. ——
CAMKK2 inhibitor 4t( —— )
Catalog No. M16972 CAS No. ——
CAMKK2 inhibitor 4t is a potent, selective, orally available, brain-penetrant CAMKK2 inhibitor with pIC50 of 8.5.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCAMKK2 inhibitor 4t
-
NoteResearch use only, not for human use.
-
Brief DescriptionCAMKK2 inhibitor 4t is a potent, selective, orally available, brain-penetrant CAMKK2 inhibitor with pIC50 of 8.5.
-
DescriptionCAMKK2 inhibitor 4t is a potent, selective, orally available, brain-penetrant CAMKK2 inhibitor with pIC50 of 8.5; potently inhibits AMPK phosphorylation in a hypothalamus-derived cell line with pIC50 of 6.3; reduces food intake in rodent models.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetCaMK
-
RecptorCaMK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight480.612
-
Molecular FormulaC30H32N4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name2-isopropyl-4-(2-(2-methyl-4-(2-morpholinoethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)benzonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Price DJ, et al. Bioorg Med Chem Lett. 2018 Apr 5. pii: S0960-894X(18)30223-3.
molnova catalog



related products
-
MLCK inhibitor pepti...
Selective competitive inhibitor of myosin light chain kinase (IC50 = 50 nM). Displays 4000-fold selectivity over CaM kinase II and does not inhibit PKA. Cell permeable.
-
Prochlorperazine
An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE.
-
Autocamtide-2-relate...
CaM kinase II inhibitor; enhanced cell permeable derivative of Autocamtide-2-related inhibitory peptide. Pretreatment blocks reinstatement of morphine-seeking behavior in vivo.